AE37: a novel T-cell-eliciting vaccine for breast cancer.

AE37: a novel T-cell-eliciting vaccine for breast cancer.

Item
http://www.wikidata.org/entity/Q37927091
New Immunotherapy Strategies in Breast Cancer.Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapyPrimary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccineInterim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer.Design and evaluation of radiolabeled tracers for tumor imaging.Therapeutic cancer vaccines: a long and winding road to success.Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.Immunotherapy for the treatment of breast cancer.Immunotherapy for breast cancer: past, present, and future.T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.Breast Cancer Immunotherapy: An Update.
P2860

AE37: a novel T-cell-eliciting vaccine for breast cancer.

Item
http://www.wikidata.org/entity/Q37927091
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
AE37: a novel T-cell-eliciting vaccine for breast cancer.
@en
AE37: a novel T-cell-eliciting vaccine for breast cancer.
@nl
type
label
AE37: a novel T-cell-eliciting vaccine for breast cancer.
@en
AE37: a novel T-cell-eliciting vaccine for breast cancer.
@nl
prefLabel
AE37: a novel T-cell-eliciting vaccine for breast cancer.
@en
AE37: a novel T-cell-eliciting vaccine for breast cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
AE37: a novel T-cell-eliciting vaccine for breast cancer.
@en
P2093
P2860
P304
P31
P356
10.1517/14712598.2011.616889
P407
P433
P478
P577
P698